Get the Stockscreener App
0.00
100.00%
-15.68
Reshape Lifesciences Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
See More
Previous Close:
$15.68
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$9.35M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
0.00
EPS:
-38.77
Net Cash Flow:
$-17.45M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$18.60
52-Week Range:
$0.00
$1,212.99
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Name
Reshape Lifesciences Inc
Sector
Industry
Phone
949-429-6680
Address
1001 CALLE AMANECER, SAN CLEMENTE
Compare RSLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
0.00 | 9.35M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
131.75 | 225.01B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.17 | 154.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
381.91 | 144.71B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.02 | 117.85B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.26 | 45.90B | 5.69B | 1.41B | 577.90M | 6.95 |
Reshape Lifesciences Inc Stock (RSLS) Latest News
Vyome Holdings, Inc. shares fall 15.75% premarket after completing merger with ReShape Lifesciences. - AInvest
Vyome Therapeutics Completes Merger with ReShape Lifesciences; Nasdaq Debut Under Ticker HIND - Sahyadri Startups
Vyome Holdings, Inc. shares fall 8.93% premarket after closing merger transaction with ReShape Lifesciences Inc. - AInvest
Vyome Therapeutics' Strategic Merger with ReShape Lifesciences: A Launchpad for US-India Biotech Synergy - AInvest
Vyome Therapeutics Completes Merger with ReShape Lifesciences - AInvest
Vyome Therapeutics Completes Merger With ReShape Lifesciences - MarketScreener
Reshape Lifesciences Reports Q2 2025 Financial Results - TipRanks
Vyome Completes Merger with ReShape Lifesciences, Set to Trade on Nasdaq as HIND - AInvest
Breaking: Clinical-Stage Biotech Vyome Finalizes ReShape Merger, Set for Nasdaq Debut as HIND Tomorrow - Stock Titan
ReShape Lifesciences Inc. SEC 10-Q Report - TradingView
ReShape Lifesciences (RSLS.O) Surges 28.4%: Is It a Short Squeeze or a New Narrative? - AInvest
ReShape Lifesciences Skyrockets 25.47%—What’s Fueling This Pre-Market Surge? - AInvest
Vyome To Begin Trading On Nasdaq Via Reverse Merger With ReShape Lifesciences Tomorrow - Nasdaq
ReShape Lifesciences Surges 31% on Nasdaq Merger Approval: A New Era for Vyome Holdings? - AInvest
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why - MSN
Why Did ReShape Lifesciences Plunge 8.75% Amid Vyome Merger? - AInvest
ReShape Lifesciences Approves Asset Sale and Merger - TipRanks
Vyome Therapeutics Inc. completed the acquisition of ReShape Lifesciences Inc. in a reverse merger transaction. - MarketScreener
Health Care Stocks Climb As Deals And Results Grab Attention - Finimize
ReShape Lifesciences Soars 66.99% on Nasdaq Merger Approval: A Biotech Merger Sparking Market Frenzy - AInvest
ReShape Lifesciences' Merger With Vyome Therapeutics Receives Nasdaq Approval for Listing - MarketScreener
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why By Stocktwits - Investing.com India
Vyome announces Nasdaq approval of merger with ReShape Lifesciences - TipRanks
Vyome Therapeutics Announces Nasdaq Approval for Merger with ReShape Lifesciences - AInvest
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND - Business Wire
Recovery Setup Building in ReShape Lifesciences Inc. Experts SayJuly 2025 Opening Moves & Verified Trade Idea Suggestions - sundaytimes.kr
ReShape Lifesciences Stock Rocketed 61% Today – Here’s Why - Stocktwits
Vyome Therapeutics Sets Board To Lead Reshape Lifesciences Post-Close; New Entity To Trade As Vyome Holdings Under Ticker Symbol HIND - 富途牛牛
MIT AI Experts Take Control: Inside Vyome's Complete Board Overhaul Before Major NASDAQ Debut - Stock Titan
How ReShape Lifesciences Inc. stock performs during market volatilityFree Portfolio Optimization Guide - newsyoung.net
ReShape Lifesciences shareholders approve merger with Vyome Therapeutics - MSN
ReShape Lifesciences Approves Asset Sale and Merger with Vyome Therapeutics - AInvest
ReShape Lifesciences RSLS 2025Q2 Earnings Preview Upside Potential on Strategic Reshape Initiatives - AInvest
ReShape Lifesciences Shareholders Approve Merger with Vyome Therapeutics, Ticker Symbol to Change to HIND - AInvest
ReShape announces shareholder approval of Vyome merger - TipRanks
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - MarketScreener
How does ReShape Lifesciences Inc. generate profit in a changing economyAccess high-quality stock research instantly - Jammu Links News
What are the latest earnings results for ReShape Lifesciences Inc.Navigate the market with precision tools - Jammu Links News
What are analysts’ price targets for ReShape Lifesciences Inc. in the next 12 monthsRapid-fire capital growth - Jammu Links News
Is it the right time to buy ReShape Lifesciences Inc. stockGet real-time alerts on top-performing stocks - Jammu Links News
How strong is ReShape Lifesciences Inc. company’s balance sheetExceptional trading results - Jammu Links News
Is ReShape Lifesciences Inc. a growth stock or a value stockCapitalize on momentum-driven opportunities - Jammu Links News
What is the dividend policy of ReShape Lifesciences Inc. stockUnlock expert trading strategies for growth - Jammu Links News
What are the technical indicators suggesting about ReShape Lifesciences Inc.Accelerated profit realization - Jammu Links News
What are ReShape Lifesciences Inc. company’s key revenue driversSpectacular growth rates - Jammu Links News
When is ReShape Lifesciences Inc. stock expected to show significant growthBuild a winning investment strategy today - Jammu Links News
What institutional investors are buying ReShape Lifesciences Inc. stockAchieve breakthrough financial results - Jammu Links News
Why ReShape Lifesciences Inc. stock attracts strong analyst attentionLow Risk Picks for Daily Trading Released - beatles.ru
ReShape Lifesciences Inc. Pullback Analyzed — Is It Time to ExitAI Forecast for Trending Stocks Indicates Upside - metal.it
ReShape Lifesciences Inc. Forms Double Bottom Pattern — Eyes on BreakoutWatchlist for Smart Swing Trading Updated - metal.it
Published on: 2025-07-29 19:35:19 - metal.it
Reshape Lifesciences Inc Stock (RSLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.74%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):